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Retinoic acid (RA) has been implicated in cardiac morphogenesis by its teratogenic effects on the heart, although its
role in normal cardiogenesis remains unknown. To define the parameters of RA action in cardiac morphogenesis, we
analyzed the patterns of ligand synthesis, response, and inactivation in the developing mouse heart. Activation of a
lacZ transgene controlled by an RA response element (RARE) was compared to the localization of the retinaldehyde-
oxidizing dehydrogenase RALDH2, the earliest RA synthetic enzyme in the mouse embryo, and to the expression of a
gene encoding an RA-degrading enzyme (P450RA). We observed that RALDH2 localization and RA response were
virtually superimposable throughout heart development. Initially, both RALDH2 and RARE-LacZ activity were
restricted to the sinus venosa in unlooped hearts, but were high in the dorsal mesocardium, while P450RA expression
was restricted to the endocardium. Later stages were characterized by a sequential, noncontiguous progression of
RALDH2 accumulation and RA response, from the sinus venosa to atria, dorsal–medial conotruncus, aortic arches, and
the epicardium. This dynamic pattern of RA response was a direct result of localized RALDH2, since hearts of cultured
embryos were uniformly competent to respond to an exogenous RA challenge. These observations support a model in
which the influence of endogenous RA on heart development depends upon localized presentation of the ligand, with
only limited diffusion from the source of its synthesis. © 1998 Academic Press
INTRODUCTION
Retinoids comprise a group of regulatory molecules
implicated in numerous biological functions in embryo-
genesis, from early patterning of the body axes to mor-
phology of organ formation (Conlon, 1995; Smith and
Dickman, 1997). The heart is one of the most sensitive
organs to perturbations of retinoid concentration
throughout its development (Kastner et al., 1994). The
profound influence of retinoids on vertebrate heart devel-
opment is illustrated by the numerous cardiac malforma-
tions induced by exposure to excess retinoids during
pregnancy, including aortic and cardiac defects such as
transposition of the great arteries, septal defects, and
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reversion of heart laterality (Pexieder et al., 1995; Dick-
man and Smith, 1996). Insufficient nutritional intake of
retinoids can also lead to an overlapping set of defects,
suggesting an important morphogenetic role for these
molecules in heart development (Twal et al., 1995).
Investigation of the mechanisms whereby retinoids
affect developmental processes have focused largely on
exposure to exogenous retinoic acid (RA), on vitamin A
deprivation, and on the inactivation of RA effector mol-
ecules by gene targeting. The dramatic teratogenicity of
retinoid excess or deficiency in vertebrate embryo-
genesis underscores the importance of regulating local
concentrations of these powerful morphogens. The sig-
nificance of RA-induced teratogenesis is limited, how-
ever, since the effects of exogenous RA do not necessarily
elucidate the physiological role of endogenous RA during
FIG. 1. RA response is highly restricted in early heart development. Ventral view of an 8.25-dpc RARE-lacZ transgenic mouse embryo (4–5
somite pairs). At this stage of development, b-gal staining is observed over trunk areas extending to the caudal neuropore (not shown). A
sharp anterior limit of transgene expression includes the prospective sinus venosa (1) and the anterior intestinal portal (2). Note that
transgene expression is completely absent from anterior portions of the heart (3).
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57Retinoic Acid in Heart Development
development. Likewise, the effects of vitamin A defi-
ciency on embryogenesis are thought to reflect critical
requirements for RA (Dickman et al., 1997; Smith and
Dickman, 1997). Yet, vitamin A deprivation during de-
velopment can only reveal the consequences of a pro-
tracted RA-deficient state and it is clear that this model
cannot provide information on the precise cellular and
temporal requirements for RA (Dickman et al., 1997).
RA and its derivatives exert their influence on tran-
scriptional control of gene expression through their ef-
fectors, the RAR and RXR families of nuclear receptors
(Mangelsdorf and Evans, 1995). The distribution of RA
effectors in the embryo yields few clues to the specificity
of their action. In situ hybridization studies show that
RARs and RXRs are widely expressed throughout the
embryo, including the forming heart (Ruberte et al., 1991;
Mangelsdorf et al., 1992; Dolle et al., 1994). Yet, congeni-
tal abnormalities in mice homozygous for null mutations
in the genes of single receptors are restricted to only a few
sites expressing those receptors during embryogenesis.
The general lack of correspondence between receptor
transcript abundance and a particular defect make it
difficult to assign specific roles to any one receptor in
heart development (Smith and Dickman, 1997). Recent
studies, however, reveal that combined ablation of RXRa
and the RAR genes has a disproportionate effect on RA
signaling. RXRa/RARb double mutants are defective in
conotruncal septation while in RXRa/RARa double mu-
tants the cephalic arteries and articopulmonary septa are
inappropriately patterned (Sucov et al., 1994; Kastner et
al., 1997a). This suggests that RXRa/RAR heterodimers
mediate proper heart development.
Endogenous retinoids are produced from conversion of
dietary vitamin A to retinol, which can be successively
oxidized to produce retinaldehyde and various forms of
RA (Means and Gudas, 1995). In addition, retinol can be
metabolized to other active ligands with diverse effects,
including 4-oxoretinol, which induces growth inhibition
of tumor cell lines (Guo and Gudas, 1998). The enzymes
that mediate these essential synthetic pathways have not
been completely characterized biochemically, and the
importance of retinoid synthetic pathways as a potential
control point in cardiac morphogenesis is as yet unkown.
In the vertebrate embryo, RA is present in the primitive
streak stage and may play a role in cardiac morphogenesis
prior to heart tube formation (Hogan et al., 1992). Cur-
rent evidence implicates the recently characterized
RALDH2 as a key enzyme catalyzing the dehydrogena-
tion of retinaldehyde to RA (Zhao et al., 1996) at these
early stages of development (7.0 –7.5 dpc). RALDH2 be-
longs to a group of NAD-dependent aldehyde dehydroge-
nases that are present in early development, as opposed to
FAD-coupled aldehyde and xanthine oxidases, which are
activated at later stages. RALDH2 is initially responsible
for the generation of endogenous RA in early embryogen-
esis (7.0 – 8.5 dpc) at a time when other RA synthetic
enzymes have not yet been activated, and it continues to
be the most abundant retinaldehyde dehydrogenase in
the trunk area throughout development (Niederreither et
al., 1997). Together with the recently described V1 reti-
naldehyde dehydrogenase activity (McCaffery and Drager,
1995), RALDH2 shows more specificity for retinaldehyde
substrate than does the previously described cytosolic class
1 aldehyde dehydrogenase, ALHD2. At early developmental
stages, both the V1 enzyme and ALHD2 are mainly ex-
pressed in the eye and face region, while RALDH2 is
responsible for most of the biosynthesis of RA in areas
caudal to the head.
A necessary prerequisite for defining the role of RA as
a morphogen during cardiogenesis is the localization of
endogenous ligand in the developing heart and the defi-
nition of the resulting regions of RA response. Previous
studies of the whole embryo have demonstrated regional
differences in RA levels (Hogan et al., 1992), and in the
expression of the RALDH2 transcript during mouse em-
bryogenesis (Niederreither et al., 1997), but neither the
distribution of RA nor its synthetic and inactivating
enzymes have been described in the heart. To ascertain
whether cardiac patterning is influenced by RA availabil-
ity or by differential sensitivity to RA stimulation, we
conducted a detailed analysis of RA responsiveness and
RALDH2 distribution during mouse heart development
(8.25–13.5 dpc). We took advantage of a previously char-
acterized RA-responsive lacZ transgene (Rossant et al.,
1991) to monitor the response to endogenous RA. We also
analyzed the expression pattern of a gene encoding a
cytochrome P450 RA-inactivating enzyme, P450RA (Fujii
et al., 1997). Our study revealed a dynamic pattern of
RALDH2 expression and RA response in the developing
mouse heart, despite the uniform competence of the
embryonic heart to respond to RA in culture. These
results indicate that RA action during this critical period
of heart development is mediated by localized ligand
synthesis.
MATERIALS AND METHODS
Transgenic Mice
Transgenic mice have been previously described (Rossant et al.,
1991) in which the bacterial lacZ gene coding for b-galactosidase
(b-gal) is driven by a heat shock promoter fused to RA-responsive
elements from the RARb promoter. Litters heterozygous for the
transgene were obtained by breeding a homozygous male with
wild-type CD1 females. Noon on the day of vaginal plug was
designated as 0.5 dpc and developmental stages were confirmed by
their morphology and somite number. For histological analysis, at
least 10 embryos were compared at all stages.
58 Moss et al.
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
Xgal, Antibody, and in Situ Hybridization Staining
Embryos and hearts spanning the stages 8.25 through 13.5 dpc
were collected and analyzed for b-gal activity, RALDH2 protein,
or P450RA transcripts. b-Gal activity was detected using Xgal as
substrate and embryos were treated as described (Cheng et al.,
1993). For immunohistochemical analysis (Dent et al., 1989), a
rabbit polyclonal RALDH2 antibody was used at a dilution of
1:200. The secondary antibody was a horseradish peroxidase-
labeled donkey anti-rabbit IgG (Amersham) used at a 1:1000
dilution. Whole mount RNA in situ hybridization was per-
formed using a P450RA cDNA clone (No. 10245), a generous gift
of Dr. H. Hamada (Fujii et al., 1997). Antisense and sense probes
were produced with T3 and T7 RNA polymerase, respectively.
Embryos were hybridized using a revised protocol (Wilkinson,
1992). The sense probe gave no detectable staining (not shown).
Embryo sections were prepared by dehydrating embryos through
an ethanol series to 95% ethanol:5% phosphate-buffered saline.
After 1 h at room temperature in JB4 infiltration resin (Poly-
sciences), embryos were transferred to molding trays, all liquid was
removed, and fresh, catalyzed JB4 resin was added. Polymerized
blocks were cut using a glass knife on a Leica No. 2065 microtome.
The resulting 5 mM serial sections were mounted onto Colorfrost
Plus slides (Fisher).
Paraffin sections were generated by standard methods (Sas-
soon and Rosenthal, 1993) and treated with 1:400 dilutions of
rabbit polyclonal RALDH2 antibody and of a monoclonal
antibody against b-gal (JIE7, DSHB) followed by a 1:800 dilution
of anti-rabbit and anti-mouse IgG– biotin conjugate (B7389 and
B7151, Sigma) and by a 1:200 dilution of an avidin–alkaline
phosphatase conjugate (E2636, Sigma). The chromogenic sub-
strate Fast Red (Sigma) was used to identify regions of RALDH2
expression and BCIP/NBT to identify regions of b-gal activity.
Embryo Cultures
Staged 8.5 dpc embryos were dissected in phosphate-buffered
medium (Cockcroft, 1990) at room temperature, carefully remov-
ing Reichert’s membrane. Embryos with beating hearts were cul-
tured in 75% rat serum:25% Dulbecco’s modified Eagle medium.
Serum was prepared as previously described (Cockcroft, 1990) from
blood obtained via the renal artery of CD1 male rats. All-trans- or
9-cis-retinoic acid (Sigma) was dissolved in DMSO to 1023 M. One
microliter of RA (to a final concentration of 1026 M) or 1 mL of
DMSO alone (untreated) was added to 1 mL of serum. Those
embryos with hearts still beating after 24 h were washed with PBS
and prepared for Xgal staining, immunohistochemistry, or whole
mount in situ hybridization.
Image Analysis and Processing
Fixed embryos were visualized on a Leica MZ8 dissecting
microscope and photographed with 160 ASA tungsten slide film.
Histological sections were photographed on a Zeiss Axiophot
microscope using 100 ASA slide film. Digital images were gener-
ated by scanning slides on a Polaroid sprint scan 35 film scanner.
RESULTS
Retinoic Acid Synthesis and Response Are Highly
Restricted within the Fused Heart Tube
To characterize the patterns of RA response in the devel-
oping mouse heart, we monitored expression patterns of a
lacZ transgene driven by the RA response element from the
RARb promoter (Rossant et al., 1991). LacZ gene expression
was extensive in caudal structures of 8.25-dpc whole mount
mouse embryos (Fig. 1) but was restricted in the heart to the
sinus venosa, the paired venous inflow tracts located at the
caudal end of the recently fused heart tube. We observed no
RA responsiveness in anterior regions of the heart at this
stage.
In transverse sections of 8.25-dpc embryos, RA response
(Fig. 2A) was localized to the neurectoderm of the unfused
neural tube and to some mesodermal structures, including
the dorsal aspect of the pericardium and the dorsal meso-
cardium. Myocardial and endocardial tissues were negative
at this stage, as was the foregut endoderm.
Retinoic Acid Response Colocalizes with the
Expression of Its Synthetic Enzyme
We hypothesized that patterns of RA response could be
linked to localized RALDH2. As monitored with a poly-
clonal antibody to the RALDH2 enzyme in transverse
sections (Fig. 2B), RALDH2 was present in the dorsal
mesocardium, while the anterior portion of the fused
heart showed no enzyme at this stage. Synthetic activity
was also absent in the foregut endoderm, indicating that
the activation of RA-responsive genes in the embryo
correlates well with localized expression of RA synthetic
enzyme.
We further examined the pattern of RALDH2 expres-
sion and RA response in embryos collected at 8.5 dpc,
when the heart tube had looped (Fig. 3). Transgenic
embryos were stained for lacZ expression to visualize RA
responsiveness (Fig. 3A), while RALDH2 was monitored
using the RALDH2 antibody in whole mount embryos
(Fig. 3B).
Although RA response in axial structures of the em-
bryo extended rostrally past the heart at this time (Fig.
3A), it did not extend ventrally into the heart beyond the
sinus venosa and atria, with the exception of a small
region in the dorsomedial conotruncus (not shown). Cra-
nially, eye tissue was RA responsive, while the tail region
was essentially negative, except for two symmetrical
areas at the base of the allantois which express RALDH2
mRNA (Niederreither et al., 1997) and RALDH2 enzyme
(not shown). This pattern of ligand response correlated
well with that of RALDH2 expression, since immunohis-
tochemical analysis of RALDH2 enzyme generated a
similar expression pattern (Fig. 3B). In the eye region,
59Retinoic Acid in Heart Development
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FIG. 4. RA synthetic enzyme and RA response colocalize in the heart while RA-inactivating enzyme is restricted to the endocardium. Sagittal
sections of 8.5-dpc RARE-lacZ transgenic embryos were stained for b-gal (A), treated with the RALDH2 antibody (B), or treated with the P450RA
antisense riboprobe (C). RA response (A) and synthesis (B) colocalize within the sinus venosa (1) and atrium (2), as well as the eye (4). The ventricle
does not synthesize or respond to RA (3). P450RA expression (C) is restricted to the endocardial cells of the sinus venosa (1) and ventricle (3).
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enhanced lacZ expression may reflect additional RA
synthesis by the V1 retinaldehyde dehydrogenase (Mc-
Caffery and Drager, 1995).
Distinct Expression Patterns of RALDH2 Synthetic
and Inactivating Enzymes
To further investigate possible control mechanisms of
RA regionalization in the embryo, we examined the
pattern of an RA-inactivating enzyme recently identified
in the mouse by Hamada and colleagues (Fujii et al.,
1997), visualized with an antisense riboprobe (P450RA,
Fig. 3C). The RA-inactivating enzyme was expressed at
very high levels in the tail region (Fig. 3C), an area low in
RALDH2 enzyme and RA response. Other regions of
P450RA expression included the hindbrain and cranial
neural crest, as well as a discrete band in the lateral plate
mesoderm in a region underlying the developing forelimb
bud (Fig. 3C).
Parasagittal sections were prepared from 8.5- to 8.75-
dpc embryos and analyzed for lacZ activity, RALDH2
enzyme, and P450RA transcripts. RA response was found
in the eye, the common atrium, and the sinus venosa (Fig.
4A), but not in the ventricle. RALDH2 was also expressed
in the walls of the sinus venosa (Fig. 4B) and atrium (Fig.
6). Transcripts encoding P450RA were found in endocar-
dial cells but not in myocardial cells of the sinus venosa
and ventricle (Fig. 4C), indicating that RA-synthetic and
-inactivating enzymes were localized in distinct patterns
at this stage of heart development.
The Embryonic Heart Is Uniformly Competent to
Respond to All-trans-Retinoic Acid
Although the RARE-lacZ transgene was activated in a
very limited pattern at a critical stage in the development
of the mouse heart (8.5 dpc), it was not clear if this
pattern reflected RA availability, or a differential sensi-
tivity to a more widespread RA stimulation. Although
all-trans-RA is the predominant retinoid ligand in the
early embryo, other forms such as 9-cis-RA have been
detected at later stages. However, current chromato-
graphic methods are relatively insensitive to adequately
quantitate 9-cis-RA (Dra¨ger and McCaffery, 1997). There-
fore, to address if transgene activation is a function of
all-trans- and 9-cis-RA availability, or differential sensi-
tivity to stimulation by these retinoids, we cultured
8.5-dpc transgenic embryos with 1 mM all-trans- or
9-cis-RA (Fig. 5), monitoring RA response, synthesis and
degradation. As seen in Fig. 5A, all cells in the 8.5-dpc
embryo were competent to respond to all-trans-RA
stimulation as previously described (Rossant et al., 1991).
In contrast, treatment with 9-cis-RA expanded the RA
response domains cranially, ventrally into the heart, and
caudally into the neuropore, but did not reproduce the
widespread activation seen for all-trans-RA. RALDH2
expression was relatively insensitive to exogenous RA
(Fig. 5B).
Analysis of the P450RA transcripts after treatment
with either of the two ligands (Fig. 5C) revealed patterns
similar but not identical to those previously described
(Fujii et al., 1997). The cranial domain of P450RA expres-
sion was upregulated and the caudal domain was down-
regulated by addition of either ligand. Both all-trans- and
9-cis-RA caused a rostral extension of expression of the
caudal domain in a thin stripe along the dorsal aspect of
the embryo. These results suggested that RA availability
was the critical step in the activation of transgene
expression in the developing heart.
A Dynamic Pattern of Retinoic Acid Synthesis and
Response during Heart Development
To explore the patterns of RALDH2 expression and RA
response in cardiac tissues, we compared the progression
of RA-induced gene expression with the pattern of
RALDH2 immunoreactivity at later stages of heart devel-
opment. Figure 6 depicts ventral views of RA response
and synthesis in embryonic hearts dissected at 1-day
intervals from 8.5 to 13.5 dpc. The unlooped heart was
initially devoid of response in all but the sinus venosa
(Fig. 1, 8.25 dpc). Subsequently, progression of RA-
induced responsiveness was rapid (Fig. 6, 8.5 dpc), show-
ing lacZ staining in the sinus venosa, common atrium,
and in the dorsomedial wall of the outflow tract. As
development proceeded (Fig. 6; 9.5 dpc), RA responsive-
ness persisted in the sinus venosa, common atrium, and
the dorsomedial wall of the conotruncus, while RALDH2
immunoreactivity was only seen in the sinus venosa and
the common atrium.
At 10.5 dpc RA responsiveness was seen throughout
the atria, in the dorsal aspect of the conotruncus, and in
a few cells in the interventricular sulcus, but was largely
absent from the ventricles. RALDH2 immunoreactivity
was also observed in the atria and over the interventricu-
lar sulcus. One discrepancy between RALDH2 enzyme
localization and response was apparent within the dorso-
medial wall of the conotruncal region as early as 8.5 dpc,
but was more pronounced at 10.5 dpc. Subsequently, RA
response at 11.5 dpc was greatly reduced, with some
residual b-gal activity still present along the dorsomedial
wall of the conotruncus. At 11.5 dpc, RALDH2 immuno-
reactivity had decreased in the atria, while the ventricles
showed a low level of staining. At 12.5 dpc, whole heart
staining revealed a major increase in RALDH2 enzyme
distribution. RA responsiveness was intense over the
ventricle, with patchy staining in the atria. By 13.5 dpc,
RA response had decreased while RALDH2 synthesis was
sustained.
To delineate in detail the patterns of RALDH2 expression
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and RA responsiveness at later stages of heart development,
when the larger size of the organ resists complete penetra-
tion of substrate or antibodies, paraffin sections of 12.5-dpc
transgenic hearts were prepared and analyzed for RALDH2
and lacZ gene products (Fig. 7). Only the ventricular epicar-
dium, but not the underlying ventricular myocardium,
showed RALDH2 immunoreactivity. Nevertheless, lacZ
gene expression extended throughout the myocardial wall
and trabeculae while the cushions did not appear to be
responsive to RA at this stage.
DISCUSSION
Embryologists have long appreciated the importance of
morphogen localization in establishing regional identity
during development. Restricted production of a ligand
with limited diffusion potential may be a key feature of
its function. Nevertheless, relatively little attention has
been paid to the synthetic and inactivating pathways
leading to local differences in retinoid concentration,
although it would seem particularly important in the
case of morphogens such as RA, which are difficult to
detect directly.
In this study we examined the correspondence of RA
synthetic activity and RA response during heart develop-
ment in the mouse. We observed a striking correlation
between the domains of RA response and immunoreactiv-
ity to a retinaldehyde dehydrogenase (RALDH2) that cata-
lyzes the last step in the RA biosynthetic pathway. These
results support a major role for RALDH2 in the control of
RA metabolism in the developing heart and indicate that
morphogenetic actions of RA in the heart are effected
through dynamic changes in the localization of its syn-
thetic enzyme, rather than by diffusion or by changes in
patterns of RA inactivation.
RALDH2 Is an Indicator of Initial RA Synthesis in
the Embryo
RA metabolism is a multistep process involving differ-
ent enzymes that metabolize retinol to RA (Means and
Gudas, 1995). The first reaction in this oxidative process
involves the oxidation of retinol to retinaldehyde by
alcohol dehydrogenases such as ADH IV (Ang et al.,
1996). RA, the functional ligand which binds receptors, is
a product of the second step, the dehydrogenation of
retinaldehyde by aldehyde dehydrogenases such as
RALDH2, suggesting that conversion of retinaldehyde to
RA, rather than the dehydrogenation of retinol to retinal-
dehyde, represents the critical step in the control of RA
biosynthesis. Although transcripts encoding alcohol de-
hydrogenases localize within the domain of RA respon-
siveness (Ang et al., 1996; Napoli, 1996), RALDH2 ex-
pression more closely reproduces the RA response
pattern (Figs. 2– 4, 6). For example, at 8.5 dpc, ADH IV
mRNA is distributed along the neural folds, trunk, and
caudal neuropore of the mouse (Ang et al., 1996), while
both RALDH2 immunoreactivity and RA response are
already restricted to the trunk regions, and are absent
from the caudal neuropore (Fig. 3).
RALDH2 also appears to play a major role during early
heart development. The analysis in Fig. 6 verifies that
patterns of RALDH2 expression are almost superimposable
to the regions of endogenous RA responsiveness. These
sharply defined patterns are summarized in diagrammatic
form in Fig. 8 and indicate that diffusion of RA, once
synthesized, must be minimal, since the heart is uniformly
competent to respond to RA in cultured embryos at 8.5 dpc
(Fig. 5).
Implications of RALDH2 Expression and RA
Response in Heart Development
The association between RA response and posterior re-
gions of the developing heart suggests a model for the
specification of cardiac inflow areas. RALDH2 is expressed
at late primitive streak stages (7.0–7.5 dpc; Niederreither et
al., 1997). At this time, most cardiac precursors have
already involuted into the primitive streak and have initi-
ated their anterior-lateral migration (Tam et al., 1997).
Therefore, only the latest cardiac precursors, the cells that
are fated to give rise to the sinus venosa and common
atrium, are likely to express RALDH2 in the primitive
streak. Thus, it is likely that the ability to synthesize RA is
an important factor in the specification of inflow structures
of the heart.
An association between RA signaling and the establish-
ment of posterior heart regions during early development
is supported by studies of vitamin A deprivation of quail
embryos (Heine et al., 1985; Dersh and Zile, 1993) as well
as administration of a monoclonal antibody against all-
trans-RA (Twal et al., 1995). Anteriorizing defects in-
cluded the formation of a single closed ventricle and the
absence of vessels such as cardinal veins and ompha-
lomesenteric veins that connect the embryonic and ex-
traembryonic circulation to the inflow area of the heart,
respectively. Alternatively, retinoid excess posteriorizes
the heart. In zebrafish embryos, administration of RA
causes deletion of anterior (ventricular) structures
(Stainier and Fishman, 1992), whereas in the chick,
excess RA causes the domains of atrial myosin heavy
chain (MHC1) expression to expand anteriorly, at the
expense of ventricular MHC1 expression (Yutzey et al.,
1994). The initial restriction of RALDH2 to posterior
regions in the developing mouse heart, as revealed in the
present study, provides additional support for the role of
RA in the specification of cardiac inflow structures.
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FIG. 5. The mouse heart is competent to respond to RA at 8.5 dpc. Dissected RARE-lacZ embryos with beating hearts were cultured in
75% rat serum/25% Dulbecco’s modified Eagle medium in the absence or presence of all-trans- or 9-cis-retinoic acid. Those embryos with
hearts still beating after 24 h were washed with PBS and stained with Xgal (A), RALDH2 immunohistochemistry (B), or a P450RA antisense
probe (C). (A) Treatment with all-trans-RA induced b-gal activity throughout the whole embryo, including the heart. Treatment with
9-cis-RA, however, produced only patchy activation of b-gal activity in the head region, heart, and caudal neuropore. (B) Treatment with
all-trans-RA induced a slight downregulation of RALDH2 immunoreactivity in trunk and caudal areas, whereas treatment with 9-cis-RA
did not. (C) P450RA expression was also influenced by treatment with RA. The cephalic domain of expression was expanded while
expression in the caudal domain was reduced posteriorly and expanded anteriorly in a thin, dorsal stripe. P450RA expression was equally
affected by either all-trans- or 9-cis-RA.
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Morphogenetic Fields of RA Signaling during
Cardiac Development
The dynamic progression of RA signaling during heart
development occurs in two waves initiated at the time
of fusion of the heart primordia (Fig. 1), when RA
response is first apparent in the sinus venosa. Shortly
after looping, RA response appears over the dorsomedial
surface of the conotruncus, while excluding the ven-
tricles. By 11.5 dpc, RALDH2 expression and RA response
are dramatically diminished throughout the heart, al-
though RA response in aortic arches is high at this time
(data not shown), suggesting that RA signaling in the
developing great vessels is controlled by a largely inde-
pendent program. At 12.5 dpc, a surge in RALDH2 occurs
in the atrial and ventricular epicardium and in RA
response within the epicardium and myocardium. There-
after, RA response decreases steadily, persisting in lim-
ited areas of the ventricle as late as 1 day after birth (data
not shown).
These patterns of RALDH2 localization and RA re-
sponse preclude a simple caudal-to-rostral progression of
RA action in the linear heart tube of the mouse. Rather,
they represent three different morphogenetic fields con-
trolled by RA during heart development. Posterior re-
gions of the heart, the inflow tract, represent the first
morphogenetic field. The second field is constituted by
the dorsomedial wall of the conotruncus, destined to
form nonmyogenic components of the mature heart, such
as the aorta, pulmonary arteries, and semilunar valves. In
this field, RA may be synthesized by a cranial neural crest
cell-associated retinaldehyde dehydrogenase other than
RALDH2 (Ang et al., 1996). The third field is represented
by the ventricles, which until 12.5 dpc are almost ex-
cluded from RA signaling. The striking contrast between
the low levels of RA metabolism in the heart at 11.5 dpc
and its dramatic increase within the ventricular epicar-
dium at 12.5 dpc suggests that the timing of exposure to
RA is critical for the proper development and expansion
of the ventricles.
Discrepancies between RALDH2 Distribution and
RA Response
During heart development, a lack of correspondence
between RALDH2 localization and RA response was
noted between 8.5 and 10.5 dpc, when lacZ staining
appeared in the dorsomedial wall of the conotruncus
where RALDH2 immunoreactivity was absent. Addition-
ally, RALDH2 enzyme expression was considerably
higher than RA response in the atria from 12.5 to 13.5 dpc
(Fig. 3). Finally, RALDH2 enzyme was present exclu-
sively in the ventricular epicardium at this stage,
whereas RA response extended throughout the myocar-
dial layers of the ventricle.
These discrepancies may reflect different biological
phenomena. At 8.5–10.5 dpc, RA response in the dorsal
conotruncus could be due to limited diffusion of RA from
the adjoining atria, which express abundant levels of
RALDH2 enzyme at this time (Fig. 6). Alternatively, RA
response in the conotruncus, an area populated by cranial
neural crest cells, may reflect RA synthesis by an enzyme
other than RALDH2. Neural crest cell-derived structures
are established targets for the teratogenic actions of RA
excess and deficiency and express RA biosynthetic en-
zymes such as ADH IV. Therefore, it is likely that
expression of ADH IV in these cells represents a source of
RA generated by a retinaldehyde dehydrogenase other
than RALDH2. This possibility is supported by studies
showing accumulation of labeled RA and expression of
the retinoic acid binding protein CRABP in cranial neural
crest cells (Denker et al., 1990).
The attenuation of RA response in the atria between
12.5 and 13.5 dpc could be due to several possible
mechanisms. Although RALDH2 immunoreactivity is
clearly present, RA levels can be downregulated either by
changes in expression of genes in the RA biosynthetic
pathway, or by posttranslational modifications of the
enzyme. Alternatively, the atria may abrogate response
to locally synthesized ligand by its inactivation or by
downregulating the components of the RA-signaling
FIG. 6. Time course of retinoic acid synthesis and responsiveness during cardiac development in the mouse. Ventral and lateral
views of hearts from 8.5- to 13.5-dpc embryos indicate colocalization of RALDH2 (left) and RA responsiveness (right). 8.5 dpc,
RALDH2 immunoreactivity and b-gal activity can be seen in the sinus venosa and in the primitive ventricle. 9.5 dpc, right lateral
view shows RALDH2 immunoreactivity in the atrium and at both right and left limbs of the sinus venosa. b-Gal activity is present
in both atrium and sinus venosa, and additionally in the dorsomedial wall of the conotruncus. 10.5 dpc, RALDH2 immunoreactivity
is present in the atria and the interventricular sulcus. b-Gal activity is present in the atria, interventricular sulcus, and the
dorsomedial wall of the contruncus. 11.5 dpc, RALDH2 immunoreactivity has receded in the atria and is restricted to limited patches
over the ventricular surface. b-Gal activity has receded in the atria and conotruncus and is completely absent from the ventricular
surface. 12.5 dpc, RALDH2 immunoreactivity appears in both atria and ventricles. b-Gal activity is dramatically increased in the
ventricles and in limited patches in the atria. 13.5 dpc, RALDH2 immunoreactivity persists in both atria and ventricles, although with
less intensity than that observed at 12.5 dpc. Similarly, b-gal activity is less intense in the ventricles, but is completely absent from
the atria.
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pathway. Current studies are being carried out to distin-
guish between these possibilities.
Finally, the restriction of RA synthetic enzyme to the
epicardium in the 12.5-dpc ventricle is not reflected in
the response of the underlying myocardial tissue (Fig. 7).
The simplest explanation for the discrepancy between
epicardial RALDH2 expression and widespread ventricu-
lar activation of RA response is that other RA synthetic
enzymes may be present in the heart by this stage.
However, it is also possible that RA generated in the
epicardium gains access to the trabeculae by circulation
through newly formed coronary vessels. These form in
the subepicardial space at 12.5 dpc (Viragh and Chalice,
1981).
A Role for RA in Myocardial Proliferation
The sudden appearance of RALDH2 in the ventricular
epicardium at 12.5 dpc may reflect a role for RA in cell
proliferation. Thickening of the ventricular wall is
achieved through expansion of the compact zone, a layer
of myocardial cells closely attached to the epicardium
(Sucov et al., 1994). In mice, this expansion is initiated at
12.5 dpc and coincides with a major surge in RA metab-
olism within the ventricular epicardium (Sucov et al.,
1994, and Fig. 7), suggesting that RA synthesis by the
epicardium constitutes a physiological signal-inducing
cell proliferation.
This role for RALDH2 in the epicardium is supported
by studies in mice in which VCAM1, a4 integrin, and
RXRa genes have been inactivated by targeted recombi-
nation. VCAM1 and a4 integrin embryos do not form a
stable epicardial covering and die of heart failure some-
times compounded by a thin myocardium and septal
defects (Kwee et al., 1995; Yang et al., 1995). RXRa
knockout mice also die because of a hypoplastic myocar-
dial wall and multiple ventricular septal defects (Sucov et
al., 1994; Kastner et al., 1994, 1997b). Notably, compact
zone cells in RXRa2/2 mice contain precocious sarco-
meric organization, suggesting that defective RA signal-
ing induces premature differentiation and growth arrest
in the compact zone (Kastner et al., 1994, 1997b), a
phenotype also displayed by vitamin A-deficient rats.
The present study reveals that proliferation of the com-
pact zone induced by RA may be initiated as early as 12.5
dpc, concomitant with the onset of RALDH2 expression
in the epicardium (Fig. 6).
A Role for RA Inactivation in Heart Development
Another means by which the activity of ligand may be
delineated is through its inactivation. Here we have
shown that in the developing 8.5-dpc heart, The RA-
inactivating enzyme P450RA was present only in the
endocardium (Fig. 4). The exclusion of RA from endocar-
dium may be critical for proper formation of conotruncal
cushions, since treatment with exogenous RA produces
atrophy of conotruncal ridges and transposition of the
great arteries (Nakajima et al., 1996). P450RA is also
expressed within rhombomere 2, in the first branchial
arch, and in the foregut epithelium as well as in the tail
region (Fig. 3; Fujii et al., 1997). Severe tail truncations
(Lohnes et al., 1993), as well as head and heart defects,
point to regions which are particularly sensitive to excess
retinoids. Exogenous treatment with RA results in exten-
sion of the domains of P450RA expression (Fig. 5; Fujii et
al., 1997), suggesting a protective mechanism against
inappropriate RA exposure.
Ligand Localization in Heart Development
This study establishes that RA signaling extends to
virtually every aspect of the developing heart, with
complex and shifting patterns of action that underscore
the important role of localized RA presentation. Al-
though RALDH2 is initially quite restricted, the devel-
oping heart is fully competent to respond to exogenously
supplied ligand. This early competence may account for
the dramatic detrimental effects of excess RA on cardiac
development, in which programs of RA-responsive gene
expression may be precociously activated.
The correspondence between RA-responsive structures
and target sites for RA-related teratogenesis suggests that
patterns of RALDH2 enzyme constitute physiological
blueprints and instructions for sequential activation of
RA-responsive gene expression during cardiac morpho-
genesis. A comprehensive description of RA signaling
should pave the way for the dissection of the normal role
of RA in individual events of cardiac development. Fur-
ther elucidation of these processes awaits the develop-
ment of spatially and temporally controlled perturbations
of ligand synthesis and inactivation, through manipula-
tion of the expression of the respective RALDH2 and
P450RA genes.
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